BEAMSTART Logo

HomePeopleProfile

Shashwata Narain

Co-founder of Veera Health 


Join Date

October 2024

Country

India

Gender

Not Specified

Age

Not Specified


About Shashwata Narain

Founder, Veera Health

Companies & Work

Veera Health

Veera Health

Veera Health is helping 110M women in India get treated for Polycystic Ovary Syndrome (PCOS). Our app combines evidence-backed therapy with coaching & specialist support for a subscription fee.

PCOS is the most common cause of infertility in women, and can lead to diabetes, depression and cancer. Patients spend up to 10 years and thousands of rupees searching for the right treatment, yet 90% are dissatisfied with existing options. With our program, 85% patients report feeling "in control" of their PCOS after just 1 month and are 4-times more likely to complete treatment.

The founders, Shobhita (COO) and Shashwata (CEO) got an inside view into this massive need when the former was diagnosed with PCOS. Shashwata studied data science at Yale University, holds an MBA from Wharton, and helped grow Fortune 100 and growth-stage consumer health / product companies at McKinsey. Shobhita studied Biology & Psychology at Tufts University and has worked with leading healthcare companies, such as GlaxoSmithKline, Accenture Life Sciences & UnitedHealth.

Share This Profile

Featured Members from India

Chetan Dalal

Founder, Weekday

Nikhil Bhaskar

CTO Kidvento

Kirushanth Kumar

Co-founder of BusinessOnBot

Rohit Pithisaria

Founder of TaxAdda

Nitthin Nair

Founder, MedPiper Technologies, Inc

Shyam Murugan

Founder, BharatX

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2025 BEAMSTART. All Rights Reserved.